These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30212017)

  • 1. [Oxalate nephropathy due to malabsorption syndrome].
    Deurvorst SE; Alberga JJ; van Tellingen A; Flens MJ
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate nephropathy associated with chronic pancreatitis.
    Cartery C; Faguer S; Karras A; Cointault O; Buscail L; Modesto A; Ribes D; Rostaing L; Chauveau D; Giraud P
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):1895-902. PubMed ID: 21737848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute oxalate nephropathy in a patient with malabsorption syndrome for chronic pancreatitis].
    Gallego Muñoz C; Manzano Martín MV
    Farm Hosp; 2015 Nov; 39(6):407-8. PubMed ID: 26618386
    [No Abstract]   [Full Text] [Related]  

  • 5. Enteric hyperoxaluria: role of microbiota and antibiotics.
    Liu M; Nazzal L
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):352-359. PubMed ID: 31145706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of patients with enteric hyperoxaluria.
    Asplin JR
    Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalate nephropathy in a diabetic patient after gastric by-pass.
    Moutzouris DA; Skaneli G; Margellos V; Apostolou T; Petraki C; Nikolopoulou N
    Clin Nephrol; 2011 Feb; 75 Suppl 1():16-9. PubMed ID: 21269587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a probiotic to decrease enteric hyperoxaluria.
    Lieske JC; Goldfarb DS; De Simone C; Regnier C
    Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.
    Moreland AM; Santa Ana CA; Asplin JR; Kuhn JA; Holmes RP; Cole JA; Odstrcil EA; Van Dinter TG; Martinez JG; Fordtran JS
    Gastroenterology; 2017 Apr; 152(5):1055-1067.e3. PubMed ID: 28089681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Green Smoothie Cleanse" Causing Acute Oxalate Nephropathy.
    Makkapati S; D'Agati VD; Balsam L
    Am J Kidney Dis; 2018 Feb; 71(2):281-286. PubMed ID: 29203127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and management of enteric hyperoxaluria.
    Desenclos J; Forté V; Clément C; Daudon M; Letavernier E
    Clin Res Hepatol Gastroenterol; 2024 May; 48(5):102322. PubMed ID: 38503362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.
    Ligon CB; Hummers LK; McMahan ZH
    Semin Arthritis Rheum; 2015 Dec; 45(3):315-20. PubMed ID: 26239907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
    Moinuddin I; Bala A; Ali B; Khan H; Bracamonte E; Sussman A
    Hum Pathol; 2016 Feb; 48():163-6. PubMed ID: 26614399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxalate nephropathy: a three-dimensional view.
    Ward A; Rosen DM; Law CC; Rosen S; Faulkner-Jones BE
    Kidney Int; 2015 Oct; 88(4):919. PubMed ID: 26422630
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute deterioration of renal function associated with enteric hyperoxaluria.
    Wharton R; D'Agati V; Magun AM; Whitlock R; Kunis CL; Appel GB
    Clin Nephrol; 1990 Sep; 34(3):116-21. PubMed ID: 2225562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of Hyperoxaluria and Kidney Disease after Combined Intestine-Kidney Transplantation for Enteric Hyperoxaluria.
    Ekser B; Mangus RS; Kubal CA; Fridell JA; Powelson JA; Nagaraju S; Mihaylov P; Phillips CL; Saxena R; Goggins WC
    Am J Nephrol; 2016; 44(2):85-91. PubMed ID: 27410399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.
    Kamel TH; Maroz N
    Am J Med Sci; 2021 Apr; 361(4):517-521. PubMed ID: 33187632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.
    Duffey BG; Alanee S; Pedro RN; Hinck B; Kriedberg C; Ikramuddin S; Kellogg T; Stessman M; Moeding A; Monga M
    J Am Coll Surg; 2010 Jul; 211(1):8-15. PubMed ID: 20610243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft.
    Hrebinko K; Moroni E; Ganoza A; Puttarajappa CM; Molinari M; Sood P; El Hag M; Wijkstrom M; Tevar AD
    Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.